Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.

The results of this controlled study of the treatment of 57 patients with Gilles de la Tourette's syndrome suggested that both haloperidol and pimozide were more effective than placebo, but that haloperidol was slightly more effective than pimozide. Adverse effects occurred more frequently with haloperidol vs placebo than with pimozide vs placebo, but the frequency was not significantly different for haloperidol compared with pimozide. Clinically significant cardiac effects did not occur at a maximum dosage of 0.3 mg/kg or 20 mg/d for pimozide and 10 mg/d for haloperidol. However, the QTc interval was prolonged during pimozide treatment compared with that during haloperidol treatment, although the values for both medications were not in an abnormal range.

[1]  J. Davis,et al.  New pharmacological approaches in the treatment of Tourette syndrome. , 1982, Advances in neurology.

[2]  Testing Hypotheses in the Two‐period Change‐over with Binary Data , 1978 .

[3]  B. Pakkenberg,et al.  Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[4]  H. Takemoto,et al.  The effect of penfluridol and some psychotropic drugs on monoamine metabolism in central nervous system. , 1975, European journal of pharmacology.

[5]  J. Gart An exact test for comparing matched proportions in crossover designs , 1969 .

[6]  J. Grizzle THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.

[7]  M. Segawa,et al.  Tourette syndrome in oriental children: clinical and pathophysiological considerations. , 1982, Advances in neurology.

[8]  A. Shapiro,et al.  Treatment of Tourette disorder with penfluridol. , 1983, Comprehensive Psychiatry.

[9]  M. Baron,et al.  Genetic analysis of Tourette syndrome suggesting major gene effect. , 1981, American journal of human genetics.

[10]  J. A. Gomes,et al.  ECG changes during haloperidol and pimozide treatment of Tourette's disorder. , 1987, The American journal of psychiatry.

[11]  U. Ungerstedt,et al.  Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.

[12]  A. Shapiro,et al.  Treatment of Gilles de la Tourette syndrome with pimozide. , 1983, The American journal of psychiatry.

[13]  G. Chouinard,et al.  Phenothiazine-induced ECG abnormalities: effect of a glucose load. , 1977, Archives of general psychiatry.

[14]  S. Matthysse Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? , 1973, Federation proceedings.

[15]  C. V. Ford,et al.  An objective evaluation of haloperidol in Gilles de la Tourette's syndrome. , 1969, Diseases of the nervous system.

[16]  H. Moldofsky,et al.  A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome. , 1978, The American journal of psychiatry.

[17]  F. Abuzzahab,et al.  Gilles de la Tourette syndrome , 1978, Neurology.

[18]  S. Enna,et al.  Overview of pharmacological approaches to therapy for Tourette syndrome. , 1982, Advances in neurology.

[19]  A. Shapiro,et al.  Pimozide treatment of tic and Tourette disorders. , 1987, Pediatrics.

[20]  B. Shaywitz,et al.  Clonidine ameliorates Gilles de la Tourette syndrome. , 1980, Archives of general psychiatry.

[21]  A. Moss,et al.  Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. , 1982, Modern concepts of cardiovascular disease.

[22]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[23]  M. Segawa,et al.  Gilles de la tourette syndrome in oriental children , 1979, Brain and Development.

[24]  A. Shapiro,et al.  Treatment of Tourette's syndrome with haloperidol, review of 34 cases. , 1973, Archives of general psychiatry.

[25]  L. Beani,et al.  Effect of haloperidol and pimozide on acetylcholine output from the cerebral cortex in rats and guinea pigs. , 1980, European journal of pharmacology.

[26]  B. Shaywitz,et al.  Clonidine in the treatment of Tourette syndrome: a review of data. , 1982, Advances in neurology.

[27]  A. Shapiro,et al.  Controlled study of pimozide vs. placebo in Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.

[28]  G. Sedvall,et al.  Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain , 1970, The Journal of pharmacy and pharmacology.

[29]  S. Snyder,et al.  Antischizophrenic drugs of the diphenylbutylpiperidine type act as calcium channel antagonists. , 1983, Proceedings of the National Academy of Sciences of the United States of America.